RFCS 0.00 Refocus Group, Inc.
| Range: | 1.0E-6-1.0E-4 | Vol Avg: | 40783 | Last Div: | 0 | Changes: | 0 |
| Beta: | -0.49 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Fri Mar 07 2003 | Empoloyees: | 4 | ||
| CUSIP: | 75865X202 | CIK: | ISIN: | US75865X2027 | Country: | US | |
| CEO: | Mr. J. Michael Judy | Website: | https://www.refocus-group.com | ||||
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow